← Back to Analyst Consensus 
ERAS Buy
Erasca, Inc.
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 14, 2026 | B of A Securities | maintain | Neutral → Neutral | — | 53% |
| Aug 13, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Aug 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 20, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 14, 2026 | B of A Securities | maintain | Neutral → Neutral | — | 53% |
| Jun 4, 2026 | B of A Securities | upgrade | Underperform → Neutral | — | 53% |
| May 12, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Apr 27, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Mar 18, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Mar 16, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Mar 13, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Mar 13, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Mar 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 6, 2026 | Clear Street | maintain | Buy → Buy | — | 48% |
| Jan 26, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $15 | 44% |
| Jan 16, 2026 | Piper Sandler | maintain | Overweight → Overweight | $11 | 54% |
| Jan 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $11 | 44% |
| Jan 7, 2026 | Piper Sandler | initiate | — → Overweight | $5 | 54% |
| Dec 9, 2025 | Mizuho | maintain | Outperform → Outperform | $5 | 52% |
| Nov 14, 2025 | Guggenheim | maintain | Buy → Buy | $5 | 52% |
| Oct 16, 2025 | Stifel | initiate | — → Buy | $4 | 53% |
| Sep 3, 2025 | B of A Securities | downgrade | Buy → Underperform | $1 | 53% |
| Aug 18, 2025 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $2 | 54% |
| Apr 30, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Mar 26, 2025 | Raymond James | initiate | — → Outperform | $5 | 54% |
| Mar 21, 2025 | Goldman Sachs | maintain | Buy → Buy | $3 | 54% |
| Mar 21, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Jan 7, 2025 | B of A Securities | upgrade | Neutral → Buy | $5 | 53% |
| Nov 18, 2024 | Jefferies | initiate | — → Buy | $6 | 52% |
| Nov 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Oct 25, 2024 | Goldman Sachs | maintain | Buy → Buy | $3.5 | 54% |
| Oct 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
| Aug 14, 2024 | Goldman Sachs | maintain | Buy → Buy | $3 | 54% |
| Aug 13, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $6 | 44% |
| May 28, 2024 | Goldman Sachs | maintain | Buy → Buy | $4 | 54% |
| May 20, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| May 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Apr 2, 2024 | Goldman Sachs | maintain | Buy → Buy | $7 | 54% |
| Mar 28, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Mar 11, 2024 | Capital One | initiate | — → Overweight | $8 | 30% |
| Jan 5, 2024 | B of A Securities | downgrade | Buy → Neutral | $6 | 53% |
| Nov 29, 2023 | Mizuho | maintain | Buy → Buy | $7 | 52% |
| Nov 28, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $8 | 44% |
| Oct 11, 2023 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| Jun 6, 2023 | Evercore ISI Group | maintain | Outperform → Outperform | $11 | 58% |
| Jun 6, 2023 | Mizuho | maintain | Buy → Buy | $8 | 52% |
| May 16, 2023 | Goldman Sachs | maintain | Buy → Buy | $9 | 54% |
| Mar 30, 2023 | Mizuho | initiate | — → Buy | $9 | 52% |
| Feb 24, 2023 | Goldman Sachs | initiate | — → Buy | $10 | 54% |
| Feb 3, 2023 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $15 | 54% |
Price Target Trend
Jul 20, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days